Page 29 - Glucose Monitoring Devices

24 CHAPTER 1 Introduction to SMBG

[33] Ikeda Y, Tajima N, Minami N, Ide Y, Yokoyama J, Abe M. Pilot study of self-
measurement of blood glucose using the dextrostix-eyetone system for juvenile-
onset diabetes. Diabetologia 1978;15:91e3. https://doi.org/10.1007/bf00422251.
[34] Howe-Davies S, Holman R, Phillips M, Turner R. Home blood sampling for plasma
glucose assay in control of diabetes. British Medical Journal 1978;2:596e8. https://
doi.org/10.1136/bmj.2.6137.596.
[35] Tattersall R. Home blood glucose monitoring. Diabetologia 1979;16:71e4. https://
doi.org/10.1007/bf01225453.
[36] Danowski T, Ohlsen P, Fisher E, Sunder J. Parameters of good control in diabetes
mellitus. Diabetes Care 1980;3:88e93. https://doi.org/10.2337/diacare.3.1.88.
[37] Peterson C, Jones R, Dupuis A, Levine B, Bernstein R, O’Shea M. Feasibility of
improved blood glucose control in patients with insulin-dependent diabetes mellitus.
Diabetes Care 1979;2:329e35. https://doi.org/10.2337/diacare.2.4.329.
[38] Cahill G, Etzwiler D, Freinkel N. Control and diabetes. New England Journal of Med-
icine 1976;294:1004e5. https://doi.org/10.1056/nejm197604292941811.
[39] Franklin Bunn H. Evaluation of glycosylated hemoglobin in diabetic patients. Diabetes
1981;30:613e7. https://doi.org/10.2337/diab.30.7.613.
[40] Skyler J, Skyler D, Seigler D, O’Sullivan M. Algorithms for adjustment of insulin
dosage by patients who monitor blood glucose. Diabetes Care 1981;4:311e8.
https://doi.org/10.2337/diacare.4.2.311.
[41] Hirsch I, Farkas-Hirsch R, Skyler J. Intensive insulin therapy for treatment of type I
diabetes. Diabetes Care 1990;13:1265e83. https://doi.org/10.2337/
diacare.13.12.1265.
[42] Consensus statement on self-monitor ing of blood glucose. Diabetes Care 1987;10:
95e9. https://doi.org/10.2337/diacare.10.1.95.
[43] The effect of intensive treatment of diabetes on the development and progression of
long-term complications in insulin-dependent diabetes mellitus. New England Journal
of Medicine 1993;329:977e86. https://doi.org/10.1056/nejm199309303291401.
[44] Self-monitoring of blood glucose. Diabetes Care 1996;19:S62e6. https://doi.org/
10.2337/diacare.19.1.s62.
[45] Intensive diabetes treatment and cardiovascular disease in patients with type 1
diabetes. New England Journal of Medicine 2005;353:2643e53. https://doi.org/
10.1056/nejmoa052187.
[46] Intensive diabetes treatment and cardiovascular outcomes in type 1 diabetes: the
DCCT/EDIC study 30-year follow-up. Diabetes Care 2016;39:686e93. https://
doi.org/10.2337/dc15-1990.
[47] Kilpatrick E, Rigby A, Goode K, Atkin S. Relating mean blood glucose and glucose
variability to the risk of multiple episodes of hypoglycaemia in type 1 diabetes. Dia-
betologia 2007;50:2553e61. https://doi.org/10.1007/s00125-007-0820-z.
[48] Evans J, Newton R, Ruta D, MacDonald T, Stevenson R, Morris A. Frequency of blood
glucose monitoring in relation to glycaemic control: observational study with diabetes
database. British Medical Journal 1999;319:83e6. https://doi.org/10.1136/
bmj.319.7202.83.
[49] Karter A, Ackerson L, Darbinian J, D’Agostino R, Ferrara A, Liu J, et al. Self-
monitoring of blood glucose levels and glycemic control: the Northern California Kai-
ser Permanente Diabetes registry. The American Journal of Medicine 2001;111:1e9.
https://doi.org/10.1016/s0002-9343(01)00742-2.